임상 한눈에 보기

• 32건의 ClinicalTrials.gov 임상 기록
• Phase·Status 요약은 enrollment 상위 표본 기준입니다
• 임상시험 탭에서 enrollment 상위 목록을 불러올 수 있습니다
• Phase: Phase 1 · Phase 3 · Phase 2 · Phase 1, Phase 2
• Status: Completed · Available · Active, not recruiting
• 주요 endpoint: Disease free survival defined as the time from randomization until the date of the first failure event will be compared for the ProstAtak® arm versus the placebo control arm. The analyses will be based on the intent to treat population. · Prostate cancer specific survival and overall survival will be compared for the ProstAtak® arm versus the placebo control arm. · PSA nadir will be compared for the ProstAtak® arm versus the placebo control arm. · Patient reported Health Related Quality of Life outcomes will be collected using the Expanded Prostate Cancer Index Composite (EPIC-26) questionnaire. The change in QOL over time will be compared for the ProstAtak® arm versus the placebo control arm. · The safety profile will be characterized by collection of adverse event information and laboratory values during the treatment phase (until the completion of radiation). Data on late effects will be collected after radiation completion.
• 등록된 결과: ORR 11%
• PFS: 0
• 핵심: This is a Phase II trial to determine the efficacy and safety of in situ gene therapy and stereotactic body radiation th…

임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.

수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.